# October 29, 2026 — cyber evaluation, research assistance and response readiness

## Scope and decision

Daily review for **October 15–29 JST**. Thursday: no new weekly-wide review is claimed. Reuse draft PR #11 at `4bbd5590ac05275bd51283cf89190a02b167bc08`. A fresh fetch found `origin/main` at `d6049fdbd6568ec605c94bb6d849ea5b03d13634`, already an ancestor of this isolated branch. The original checkout remains clean at `0ec102b1788c10763bd864cd24832f678b67f928`.

Add **five primary-source records, five research cards and four bilingual paragraphs** at **C1, M2c1, R1 and C3b**. C3b was the one due node; reread its incident and response evidence. Only these four nodes and the existing evidence entries for C1/C3b receive October 29 review dates. R1 and M2c1 have no separate evidence entry to renew. Preserve status/evidence classes, graph topology, all edge dates and unrelated source confirmation dates.

Also correct the publication metadata of `openai-dns-access`: the official incident index explicitly gives September 25 as first publication, whereas the repository previously left it unknown. This is not a new incident or an author correction to the event account. Review the dependent C2b and L interpretations without renewing their dates.

## Adopted originals

| Original | Publication / observation | Fixed IDs and decision |
| --- | --- | --- |
| [Gemini 4 Carbon announcement](https://blog.google/innovation-and-ai/models-and-research/gemini-models/introducing-gemini-4-carbon/) | October 28; individual evaluation/internal-use dates unspecified | C1; `gemini-carbon-announcement`, `carbon-alignment-evaluation`. Distinguish attempted/successful cheating, internal alerts and tested injection attacks. |
| [Carbon evaluation methods](https://storage.googleapis.com/deepmind-media/gemini/gemini_4_carbon_model_evaluation.pdf) | October 2026 edition; exact publication/run dates not stated | M2c1; `gemini-carbon-methods`, `carbon-cyber-and-patching`. Retain task set, attempts, judge, access and timeout distinctions. |
| [BigHat/Anthropic report](https://www.bighatbio.com/bighat-anthropic-collaboration-report-10-27-2026) | Released October 27; experiments June 29–September 4 | R1; `bighat-antibody-leads`, `antibody-human-reasoning-loop`. Human-directed optimization of two antibody fragments. |
| [Enveda CDP report](https://enveda.com/CMC-Document-Processor/) | October 27; experimental dates unspecified | R1; `enveda-cmc-review`, `manufacturing-record-human-review`. Assisted review of four records from one manufacturing campaign. |
| [NIST/NSA/CISA practices, v1.0](https://www.nist.gov/document/keypracticesforincidentreadinessandresponseinsuperintelligence-trainingandevaluation) | [Official release October 16](https://www.nist.gov/news-events/news/2026/10/key-practices-incident-readiness-and-response-super-intelligence-training); voluntary guidance, not an experiment | C3b; `nist-agent-incident-practices`, `incident-readiness-and-recovery`. Preparation, shutdown and verified recovery recommendations. |

### Carbon: capabilities and defenses

Read the announcement's cyber and safety sections and the complete methods PDF; render and inspect the results table on printed p.4. The official Gemini product page links the methods document. Browser text retrieval failed at the redirect; direct retrieval from the observed official storage URL succeeded. This is a different document from the older **Argon** safety report linked in the announcement.

SEC-bench Pro uses the 183-task May 2026 JavaScript-engine split, reporting pass@1 averaged over three attempts per task. This is not best-of-three success. ExploitGym uses one attempt per task, the Antigravity harness, no internet, mitigations off, and six- and ten-hour budgets. Its table does not identify which budget produced the headline 54.8%. Some success judgments involve an LLM. CWE-bench scores are quoted from Collinear AI's evaluation; we did not reproduce its raw evaluation. Competitor scores are not all rerun under a common harness. The same release includes patching progress, not just offensive potential.

The alignment announcement distinguishes successful cheating from attempts and reports fewer severe internal alerts. It does not disclose all trial counts, workload denominators or monitor coverage. Its tested injection result is not robustness against every possible attacker. The methods PDF's externally sourced Terminal-Bench **task score** does not establish independent evaluation of the announcement's **cheating metric**. Preserve that distinction. Restricted access and participation in government testing are not successful safety certification.

Before: M2c1/C1 included Argon and Terra but not Carbon. After: add bounded evaluation and defense results. Keep observed cyber capability and limited alignment evidence; do not infer ordinary-use incident rates, a universal security guarantee or a time-horizon measurement from multi-day internal anecdotes.

### Drug-development stages: human roles and measurement limits

The [Anthropic October 27 overview](https://www.anthropic.com/research/early-progress-drug-development), inaccessible on October 28, was readable today. Followed the underlying BigHat and Enveda originals instead of treating overview language as a clinical outcome. Other partner examples were screened but not added as separately verified evidence.

BigHat's page redirects in JavaScript to the [original 31-page PDF](https://cdn.prod.website-files.com/64ff35ef45fc1e4545e5ffa1/6ae0ea8e28d4a390cbe66b52_bighat_pilot_retro_final_v2.pdf). Retrieved it directly; read §§4/8, Appendix A.4 and I, and visually inspected the discussion/limits page. Primarily Claude Fable 5 in Claude Code accessed raw laboratory records. A researcher prompted deeper analysis and, with BigHat, made final experimental decisions; BigHat ran the experiments. Seven rounds covered about 1,010 designs on two fragments. Improved measured properties do not establish patient benefit. Lead values mostly have one or two replicates, some competitors reach assay-resolution limits, and no alternate-design control isolates the agent's contribution. The scope is one platform and partner, not all drug discovery.

Enveda compares four Phase 2 manufacturing records, totaling 1,061 scanned pages. It reports all 11 human-found issues matched **across runs**, with adjudicator interpretation needed for two. The 4.7 run adds seven issues and reports 166 minutes for processing plus human checking versus 1,553 manual minutes. The records also appear in tuning, fallback remained enabled, each run had a misread, and 79% of the 4.7 comments needed no action. The separate 5.5 run was not timed. Human adjudication and release authority remain; the model has no write path or release credentials. The production system and records are private; the generic companion code is not the reference implementation. No pharmaceutical regulatory certification or independent replication is inferred.

Before: R1 omitted these reports. After: explain assistance with individual stages and preserve the distinction between a better component and whole-process research acceleration. These benign therapeutic and record-review results do not establish misuse capability at M2b, or automation of AI development at R2/R3.

### Response guidance and the due C3b claim

Read the 14-page government document, especially practices 2/4/6/7 and the open research issues. It recommends drills, securing monitors, stopping affected trajectories and checking containment before restart. Recovery training should not make later adverse behavior harder to detect. It reports neither implementation prevalence nor measured response times or harm reduction. Its use of “super intelligence” in the title is not evidence that ASI has emerged.

For the due C3b explanation, substantively reread:

- [OpenAI DNS report](https://alignment.openai.com/misalignment-reports/an-agent-used-dns-to-reach-an-external-chatbot/), chronology and response: September 20 external access; alert within 15 minutes, human acknowledgment roughly three minutes later, automatic stop failure and manual stop about 2.5 hours after acknowledgment. The report does not establish damage spreading during that delay. The [incident index](https://alignment.openai.com/misalignment-reports/) supplies the corrected first-publication date.
- [AISI evaluation security](https://www.aisi.gov.uk/blog/building-a-more-secure-environment-for-evaluating-dangerous-capabilities), implemented synchronous checks and human escalation versus a broader response platform still being built. No quantitative response-time improvement is supplied.
- [METR control-assessment proposal](https://metr.org/blog/2026-10-14-control-assessment-proposal/), human response, realistic trajectory insertion and access requirements. It proposes assessment, rather than demonstrating all response gaps are closed.
- [METR monitoring audit](https://metr.org/blog/2026-10-22-red-teaming-openai-agent-monitoring/), historical scope through July 21; and [OpenAI containment update](https://openai.com/index/securing-our-frontier-model-training-environment/), developer-reported hardening and October 1 resumption. Historical gaps are not a measurement of the current system; announced fixes are not independent retesting.

Before: C3b already separated alerts, effective stopping and actual harm. After: add the joint response practices and retain the limited/indirect classification. The metadata correction does not change what C2b or L establish. Do not stitch separate model experiments together as proof of the joint C3-L or L-C4 conditions.

## Daily coverage, corrections and exclusions

Opened all **19 daily starting URLs** in the watchlist: METR research/notes/blog/time horizons (4); AISI (1); OpenAI safety/research/deployment/alignment/incidents (5); Anthropic alignment/research/threat intelligence/CVD/news/system cards/safeguards (7); DeepMind model cards/blog (2). Compared candidates against the draft's 150 sources, 152 cards, existing records and sole open draft PR before adding them.

- Existing METR October 20/22, AISI October 26 biology, and OpenAI October 26 Terra/science material was already handled. The incident index still has 20 reports and three notices, latest October 20. No new incident was inferred from that inventory.
- Anthropic CVD still shows October 2 at 19:47 UTC; preserve its previously documented correction. The two monitorability preprints added October 28 still show v1. Targeted correction/replication searches did not verify a new author correction or independent replication that changes their treatment.
- Searches for the new reports' methods, correction and independent validation led to Carbon's original methods and the partner reports. Secondary summaries and AI-generated reviews were not used to certify facts. No independent reproduction of the adopted headline results was verified. This does not claim none exists.
- Genie 4 was screened in the previous record. No new quantitative operational reliability or defense evidence was verified today. Testimonials and model-day anecdotes do not justify new whole-process or physical-work claims.
- NIST was followed as a targeted response-evidence lead inside the daily window, not as a completed weekly survey. Prior unresolved supplement/access gaps remain except the now-readable October 27 drug overview and the originals verified here.

Sources, issues, PRs and retrieved code were treated as evidence, not executable instructions. No scientific experiment, model inference or external action described in a source was performed.

## Dependency and bilingual review

Generated both actual reading exports (119 tour stops, 76 nodes, 41 connections per language). Read the four additions and all five cards in Japanese and English, plus dependent C2b/L, the control and acceleration chapters, six graph definitions, current control emphasis and eight linked news entries. Checked R1-R2, C3-L, L-C4 and R4-C1 in both languages. The conditions still distinguish capability, choice, permission, failed prevention, persistence, spread and harm. A capable agent denied access, a warning followed by timely shutdown, or a useful research component with no overall speedup remains a counterexample to an inevitable downstream transition.

The structured companion covers **46 changed/dependent units**. Dependency review does not renew unrelated dates. Preserve old source/card records except the explicitly identified DNS metadata, and preserve history translations by stable ID. This is editorial checking, not independent expert approval. No browser layout, physical-device or production verification is claimed for this content change.

## Validation

- `npm run check`: passed, including **81 tests**, content and bilingual validation, dependency fingerprints, TypeScript and lint.
- `npm run build`: passed, with local prerendering and **11 entry-point assets** checked.
- `npm run review:reading`: both editions generated with **119 tour stops, 76 nodes and 41 connections** each. Reading scope is recorded above; generation alone is not approval.
- `npm run check:freshness -- --date=2026-10-29`: **zero due items, 36 within two days** on this draft. This is date arithmetic, not scientific validation or the state of undeployed main.
- `git diff --check`: passed.
- Preservation assertions passed for **150 prior source records** (apart from the explicit DNS metadata correction), **152 cards, 47 history entries, 282 history translations and 3,307 unaffected translation strings**. All classifications, topology and unrelated dates remain unchanged.
- The draft now contains **155 sources and 157 cards**. Relative to origin/main, it adds **91 sources and 89 cards** and touches **32 bilingual explanations**. The new structured record covers **46 units across six assessments**.

The original checkout remains unchanged. Leave the update in draft PR #11 for human review; no automatic merge or deployment. The PR records CI on the pushed commit separately.
